You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKesson
McKinsey
Harvard Business School
Baxter
AstraZeneca

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for FARXIGA


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for FARXIGA (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $195,622,206
INSIDE ANOTHER STORE $192,423,137
[disabled in preview] $558,029,351
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 157,962
INSIDE ANOTHER STORE 405,063
[disabled in preview] 1,076,211
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $47,896,999
MEDICARE $222,495,168
[disabled in preview] $675,682,527
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for FARXIGA
Drug Units Sold Trends for FARXIGA

Annual Sales Revenues and Units Sold for FARXIGA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
FARXIGA   Start Trial   Start Trial 2017
FARXIGA   Start Trial   Start Trial 2016
FARXIGA   Start Trial   Start Trial 2015
FARXIGA   Start Trial   Start Trial 2014
FARXIGA   Start Trial   Start Trial 2013
FARXIGA   Start Trial   Start Trial 2012
FARXIGA   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
McKesson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.